Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver

NCT00041808 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastases, Neoplasm
Colorectal Neoplasms
Esophageal Neoplasms
Stomach Neoplasms
Pancreatic Neoplasms
Breast Neoplasms
Melanoma
Sarcoma
Gastrointestinal Neoplasms
Lung Neoplasms
Liver Neoplasms
Cholangiocarcinoma

Interventions

DRUG: MTC-DOX for Injection
PROCEDURE: Chemotherapy

Sponsor

FeRx